Sandoz Symposium on the occasion of the 8th World Congress of Cardiology, Tokyo, September 17-23, 1978. Pharmacokinetics and clinical pharmacology of beta-blockers in hypertension.

No abstract is available for this paper.

• Publication year

  1979

• Venue

  The Cardiology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 42482
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• A comparative evaluation of propranolol pharmacokinetics in obese versus ideal weight individuals: A blueprint towards a personalised medicine.

  2023cites this paper
• Effect of cardiopulmonary bypass on the pharmacokinetics of propranolol and atenolol.

  2009cites this paper
• Cardiopulmonary bypass alters the pharmacokinetics of propranolol in patients undergoing cardiac surgery.

  2005cites this paper
• Elimination of pindolol in liver disease

  2004cites this paper
• Metabolism of pindolol in patients with renal failure

  2004cites this paper
• Pharmacokinetics of pindolol in Kenyan Africans

  2004cites this paper
• A pharmacodynamic and pharmacokinetic comparison of pindolol 20 mg retard and a conventional tablet

  2004cites this paper
• Beta-adrenergic blockade for the treatment of hyperthyroidism.

  1992cites this paper
• Qualities of an ideal beta-adrenoceptor antagonist and comparison of existing agents with a new cardioselective hydrophilic vasodilator beta-adrenoceptor antagonist, celiprolol.

  1988cites this paper
• Biliary excretion and enterohepatic circulation of two beta-adrenergic blocking drugs, exaprolol and propranolol, in rats.

  1984cites this paper
• Unsuitability of urethane anesthetized rats for testing potential β-adrenoreceptor blockers

  1982cites this paper
• Beta-adrenergic antagonists in the treatment of patients with heart disease.

  1981cites this paper